Stage II Breast Cancer Completed Phase Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01293032Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast CancerTreatment